PM&R
Volume 2, Issue 3 , Pages S19-S25 , March 2010

Pediatric Rehabilitation: 3. Facilitating Family-Centered Treatment Decisions

  • Elizabeth Moberg-Wolff, MD

      Affiliations

    • Department of PM&R, Medical College of Wisconsin, 999 N92nd St, Suite CCC 350, Milwaukee, WI 53201; Children's Hospital of Wisconsin, Milwaukee, WI⁎
    • Corresponding Author InformationAddress correspondence to: E.M.-W.
    • ,
  • Chong Tae Kim, MD, PhD

      Affiliations

    • Department of PM&R and Pediatrics, University of Pennsylvania; The Children's Hospital of Philadelphia, Philadelphia, PA†
    • ,
  • Nancy Murphy, MD

      Affiliations

    • Division of General Pediatrics, University of Utah, Salt Lake City, UT‡
    • ,
  • Melissa Trovato, MD

      Affiliations

    • Department of PM&R, Johns Hopkins University, School of Medicine, Baltimore, MD; Kennedy Krieger Institute, Baltimore, MD§
    • ,
  • Heakyung Kim, MD

      Affiliations

    • Department of PM&R and Pediatrics, University of Pennsylvania, School of Medicine; The Children's Hospital of Philadelphia∥

References 

  1. Bruehl S, Chung OY. Psychological and behavioral aspects of complex regional pain syndrome management. Clin J Pain. 2006;22:430–437
  2. Maillard SM, Davies K, Khubchandani R, Woo PM, Murray KJ. Reflex sympathetic dystrophy: A multidisciplinary approach. Arthritis Rheum. 2004;51:284–290

    ⁎

  3. Wilder RT, Berde CB, Wolohan M, Vieyra MA, Masek BJ, Micheli LJ. Reflex sympathetic dystrophy in children (Clinical characteristics and follow-up of seventy patients). J Bone Joint Surg [Am]. 1992;74:910–916

    ⁎

  4. Gallagher RM. Rational integration of pharmacologic, behavioral, and rehabilitation strategies in the treatment of chronic pain. Am J Phys Med Rehabil. 2005;84(3 Suppl):S64–S76
  5. Harden RN, Cole PA. New developments in rehabilitation of neuropathic pain syndromes. Neurol Clin. 1998;16:937–950
  6. Konijnenberg AY, de Graeff-Meeder ER, van der Hoeven J, Kimpen JL, Buitelaar JK, Uiterwaal CS. Pain of Unknown Origin in Children Study Group (Psychiatric morbidity in children with medically unexplained chronic pain: diagnosis from the pediatrician's perspective). Pediatrics. 2006;117:889–897

    ⁎

  7. Roth-Isigkeit A, Thyen U, Stoven H, Schwarzenberger J, Schmucker P. Pain among children and adolescents: restrictions in daily living and triggering factors. Pediatrics. 2005;115:e152–e162
  8. Lynch ME. Psychological aspects of reflex sympathetic dystrophy: a review of the adult and paediatric literature. Pain. 1992;49:337–347
  9. Cimaz R, Matucci-Cerinic M, Zulian F, Falcini F. Reflex sympathetic dystrophy in children. J Child Neurol. 1999;14:363–367
  10. Vetter TR. A clinical profile of a cohort of patients referred to an anesthesiology-based pediatric chronic pain medicine program. Anesth Analg. 2008;106:786–794

    ⁎

  11. Laxer RM, Allen RC, Malleson PN, Morrison RT, Petty RE. Technetium 99m-methylene diphosphonate bone scans in children with reflex neurovascular dystrophy. J Pediatr. 1985;106:437–440
  12. Driessens M, Blockx P, Geuens G, Diji H, Verheyen G, Stassijns G. Pseudoatrophy (A conversion disorder mimicking reflex sympathetic dystrophy). Acta Orthopead Belgica. 2002;68:330–336
  13. Stanton RP, Malcolm JR, Wesdock KA, Singsen BH. Reflex sympathetic dystrophy in children: an orthopedic perspective. Orthopedics. 1993;16:773–779
  14. Meighen KG. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder. J Child Adolescent Psychopharmacol. 2007;17:121–127
  15. Barkin RL, Barkin S. The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy. Am J Therapeutics. 2005;12:431–438

    ⁎

  16. Kirwin JL, Goren JL. Duloxetine: A dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy. 2005;25:396–410
  17. Kozlowska K, Rose D, Khan R, Kram S, Lane L, Collins J. Family-based assessment and treatment: A conceptual model and practice framework for managing chronic pain in children and adolescents. Harvard Rev Psychiatry. 2008;16:136–150
  18. Mailis-Gagnon A, Giannoylis I, Downar J, et al. Altered central somatosensory processing in chronic pain patients with “hysterical” anesthesia. Neurology. 2003;60:1501–1507

    ⁎

  19. Wu WH, Bandilla E, Ciccone DS, et al. Effects of qigong on late-stage complex regional pain syndrome. Alternative Therap Health Med. 1999;5:45–54
  20. Gainer MJ. Somatization of dissociated traumatic memories in a case of reflex sympathetic dystrophy. Am J Clin Hypnosis. 1993;36:124–131
  21. Wong CS, Kuo CP, Fan YM, Ko SC. Collateral meridian therapy dramatically attenuates pain and improves functional activity of a patient with complex regional pain syndrome. Anesth Analg. 2007;104:452
  22. Hill SD, Lin MS, Chandler PJ. Reflex sympathetic dystrophy and electroacupuncture. Texas Med. 1991;87:76–81
  23. Barowsky EI, Zweig JB, Moskowitz J. Thermal biofeedback in the treatment of symptoms associated with reflex sympathetic dystrophy. J Child Neurol. 1987;2:229
  24. Dietz FR, Mathews KD, Montgomery WJ. Reflex sympathetic dystrophy in children. Clin Orthop Related Res. 1990;258:225–231
  25. Sherry DD, Wallace CA, Kelley C, Kidder M, Sapp L. Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy. Clin J Pain. 1999;15:218–223
  26. Murray CS, Cohen A, Perkins T, Davidson JE, Sills JA. Morbidity in reflex sympathetic dystrophy. Arch Dis Childhood. 2000;82:231–233
  27. Low AK, Ward K, Wines AP. Pediatric complex regional pain syndrome. J Pediatr Orthoped. 2007;27:567–572

    ⁎

  28. Martin AL, McGrath PA, Brown SC, Katz J. Children with chronic pain: impact of sex and age on long-term outcomes. Pain. 2007;128:13–19
  29. Veldman PH, Goris RJ. Multiple reflex sympathetic dystrophy (Which patients are at risk for developing a recurrence of reflex sympathetic dystrophy in the same or another limb). Pain. 1996;64:463–466

    ⁎

  30. Flato B, Aasland A, Vandvik IH, Forre O. Outcome and predictive factors in children with chronic idiopathic musculoskeletal pain. Clin Exp Rheumatol. 1997;15:569–577
  31. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Box M, Damiano D, et al. Dev Med Child Neurol. 2007;109:8–14Erratum in Dev Med Child Neurol 49:480
  32. Murphy N, Such-Neibar T. Cerebral palsy diagnosis and management: the state of the art. Curr Probl Pediatr Adolesc Health Care. 2003;33:146–169

    ⁎

  33. Tilton AH. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol. 2004;11:58–65
  34. Newman CJ, O'Regan M, Hensey O. Sleep disorders in children with cerebral palsy. Dev Med Child Neurol. 2006;48:564–568

    ⁎

  35. Doran SM, Harvey MT, Horner RH. Sleep and developmental disabilities: assessment, treatment, and outcome measures. Ment Retard. 2006;44:13–27
  36. Phillips L, Appleton RE. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol. 2004;46:771–775
  37. Houlihan CM, O'Donnell M, Conaway M, Stevenson RD. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol. 2004;46:305–310
  38. Berker AN, Yalcin MS. Cerebral palsy: Orthopedic aspects and rehabilitation. Pediatr Clin North Am. 2008;55:1209–1225ix

    ⁎

  39. Brehaut JC, Kohen DE, Raina P, et al. The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers?. Pediatrics. 2004;114:e182–e191
  40. Murphy NA, Christian B, Caplin DA, Young PC. The health of caregivers for children with disabilities: Caregiver perspectives. Child Care Health Dev. 2007;33:180–187
  41. Samdup DZ, Smith RG, Il Song S. The use of complementary and alternative medicine in children with chronic medical conditions. Am J Phys Med Rehabil. 2006;85:842–846
  42. Eisenberg DM, David RB, Ettner SL, et al. Trends in alternative medicine use in the US, 1990-1997. JAMA. 1998;280:1569–1575
  43. Counseling Families Who Choose Complementary and Alternative Medicine for Their Child With Chronic Illness or Disability. Committee on Children with Disabilities. Pediatrics. 2001;107:598–601aappolicy.aappublications.org/cgi/reprint/pediatrics;107/3/598.pdfAccessed March 1, 2009
  44. National Center for Complementary and Alternative Medicine. www.nccam.nih.gov/nccam/resources/camAccessed March 1, 2009
  45. Siblinga EM, Ottolini MC, Duggan AK, Wilson MH. Parent-pediatrician communication about complementary and alternative medicine use for children. Clin Pediatr. 2004;45:367073
  46. Moore D, Kowalske K. Neuromuscular rehabilitation and electrodiagnosis: myopathy. Arch Phys Med Rehab. 2000;81:S34–S35
  47. Messina B. Herbal supplements: Facts and myths–talking to your patients about herbal supplements. J Perianesthesia Nurs. 2006;21:268–278
  48. Physicians Desk Reference for Herbal Medicines. 4th ed.. Atlanta, GA: Thomson Healthcare Inc; 2007;
  49. McDonagh M, Helfand M, Carson S, Russman BS. Hyperbaric oxygen therapy for traumatic brain injury: A systematic review of the evidence. Arch Phy Med Rehabil. 2004;85:1198–1204
  50. McDonagh M, Carson S, Ash J, et al. Hyperbaric oxygen therapy for brain injury, cerebral palsy and stroke. Evidence Report Number 85. Agency for Healthcare Research and Quality. U.S. Department of Health and Human Services. September 2003. AHRQ Pub No 03-E050.
  51. Inter American Conductive Education Association. www.iacea.orgAccessed March 1, 2009
  52. Reddihough DS, King J, Coleman G, Catanese T. Efficacy of programs based on conductive education for young children with cerebral palsy. Dev Med Child Neurol. 1998;40:763–767
  53. The Adeli Suit Update. Cerebral Palsy International Research Foundation. Fact Sheet 226. www.cpirf.org/fact-sheets-226November 1, 2004;Accessed March 1, 2009
  54. Bar-Haim S, Harries N, Belokopytox M, et al. Comparison of efficacy of Adeli suit and neurodevelopmental treatments in children with cerebral palsy. Dev Med Chid Neurol. 2006;48:325–330
  55. Mehta T, Feroz A, Thakkar U, Vanikar A, et al. Subarachnoid placement of stem cells in neurological disorders. Transplant Proc. 2008;40:1145–1147
  56. Harting MT, Sloan LE, Jimenez F, Baumgartners J, Cox CS. Subacute neural stem cell therapy for traumatic brain injury. J Surg Res. 2008 Apr 23;(epub). PMID 18694578
  57. Cohen M. Legal and Ethical issues relating to Use of Complementary therapies in pediatric hematology/oncology. J Pediatr Hematol Oncol. 2006;28:190–193
  58. Vohra S, Cohen MH. Ethics of complementary and alternative medicine use in children. Pediatr Clin N Am. 2007;54:875–884

    ⁎

  59. Centre for Evidence Based Medicine. www.cebm.netAccessed March 1, 2009
  60. Renella R, Fanconi S. Decision making in pediatrics: A practical algorithm to evaluate complementary and alternative medicine for children. Eur J Pediatr. 2006;165:437–441

    ⁎

  61. Stacin T, Wade S, Walz N, Yeastes K, Taylor G. Traumatic brain injuries in early childhood: Initial impact on the family. J Dev Behavior. 2008;29:253–261
  62. Wade S, Taylor G, Yeates K, Drotar D, et al. Long term parental and family adaptation following pediatric brain injury. J Pediatr Psych. 2006;21:1072–1083
  63. Institute of Medicine at the National Academy of Sciences. Report on Use of Complementary and Alternative Medical Therapies. Washington, DC: NAS Press; 2005;

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(09)01641-4

doi: 10.1016/j.pmrj.2009.12.003

PM&R
Volume 2, Issue 3 , Pages S19-S25 , March 2010

Article Tools